Q1 Earnings Forecast for OPCH Issued By Barrington Research

Option Care Health, Inc. (NASDAQ:OPCH) – Research analysts at Barrington Research raised their Q1 2025 earnings per share (EPS) estimates for shares of Option Care Health in a report released on Tuesday, January 14th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $0.22 for the quarter, up from their prior estimate of $0.20. Barrington Research currently has a “Outperform” rating and a $33.00 target price on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.21 per share. Barrington Research also issued estimates for Option Care Health’s Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.20 EPS and FY2026 earnings at $1.42 EPS.

A number of other research analysts also recently issued reports on the stock. UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Truist Financial lowered their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.86.

Option Care Health Price Performance

OPCH opened at $28.76 on Thursday. The firm has a market capitalization of $4.89 billion, a PE ratio of 24.17, a price-to-earnings-growth ratio of 2.44 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business’s 50-day moving average is $23.33 and its two-hundred day moving average is $27.70. Option Care Health has a 1 year low of $21.39 and a 1 year high of $34.63.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. American Century Companies Inc. grew its holdings in Option Care Health by 0.5% during the second quarter. American Century Companies Inc. now owns 1,154,215 shares of the company’s stock worth $31,972,000 after acquiring an additional 5,614 shares during the period. Federated Hermes Inc. boosted its position in Option Care Health by 5.5% in the 2nd quarter. Federated Hermes Inc. now owns 20,621 shares of the company’s stock worth $571,000 after purchasing an additional 1,073 shares in the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of Option Care Health by 15.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 65,075 shares of the company’s stock worth $1,803,000 after purchasing an additional 8,695 shares during the period. Envestnet Asset Management Inc. increased its holdings in shares of Option Care Health by 2.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock valued at $6,407,000 after purchasing an additional 6,283 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new position in shares of Option Care Health in the 2nd quarter valued at $68,003,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.